• Je něco špatně v tomto záznamu ?

Multiscale Analysis of Extracellular Matrix Remodeling in the Failing Heart

AR. Perestrelo, AC. Silva, J. Oliver-De La Cruz, F. Martino, V. Horváth, G. Caluori, O. Polanský, V. Vinarský, G. Azzato, G. de Marco, V. Žampachová, P. Skládal, S. Pagliari, A. Rainer, P. Pinto-do-Ó, A. Caravella, K. Koci, DS. Nascimento, G. Forte

. 2021 ; 128 (1) : 24-38. [pub] 20201027

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články, práce podpořená grantem, audiovizuální média

Perzistentní odkaz   https://www.medvik.cz/link/bmc21026212

RATIONALE: Cardiac ECM (extracellular matrix) comprises a dynamic molecular network providing structural support to heart tissue function. Understanding the impact of ECM remodeling on cardiac cells during heart failure (HF) is essential to prevent adverse ventricular remodeling and restore organ functionality in affected patients. OBJECTIVES: We aimed to (1) identify consistent modifications to cardiac ECM structure and mechanics that contribute to HF and (2) determine the underlying molecular mechanisms. METHODS AND RESULTS: We first performed decellularization of human and murine ECM (decellularized ECM) and then analyzed the pathological changes occurring in decellularized ECM during HF by atomic force microscopy, 2-photon microscopy, high-resolution 3-dimensional image analysis, and computational fluid dynamics simulation. We then performed molecular and functional assays in patient-derived cardiac fibroblasts based on YAP (yes-associated protein)-transcriptional enhanced associate domain (TEAD) mechanosensing activity and collagen contraction assays. The analysis of HF decellularized ECM resulting from ischemic or dilated cardiomyopathy, as well as from mouse infarcted tissue, identified a common pattern of modifications in their 3-dimensional topography. As compared with healthy heart, HF ECM exhibited aligned, flat, and compact fiber bundles, with reduced elasticity and organizational complexity. At the molecular level, RNA sequencing of HF cardiac fibroblasts highlighted the overrepresentation of dysregulated genes involved in ECM organization, or being connected to TGFβ1 (transforming growth factor β1), interleukin-1, TNF-α, and BDNF signaling pathways. Functional tests performed on HF cardiac fibroblasts pointed at mechanosensor YAP as a key player in ECM remodeling in the diseased heart via transcriptional activation of focal adhesion assembly. Finally, in vitro experiments clarified pathological cardiac ECM prevents cell homing, thus providing further hints to identify a possible window of action for cell therapy in cardiac diseases. CONCLUSIONS: Our multiparametric approach has highlighted repercussions of ECM remodeling on cell homing, cardiac fibroblast activation, and focal adhesion protein expression via hyperactivated YAP signaling during HF.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc21026212
003      
CZ-PrNML
005      
20211026133119.0
007      
ta
008      
211013s2021 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1161/CIRCRESAHA.120.317685 $2 doi
035    __
$a (PubMed)33106094
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Perestrelo, Ana Rubina $u International Clinical Research Center, St. Anne's University Hospital Brno, Czech Republic (A.R.P., J.O.-D.L.C., F.M., V.H., G.C., O.P., V.V., S.P., K.K., G.F.)
245    10
$a Multiscale Analysis of Extracellular Matrix Remodeling in the Failing Heart / $c AR. Perestrelo, AC. Silva, J. Oliver-De La Cruz, F. Martino, V. Horváth, G. Caluori, O. Polanský, V. Vinarský, G. Azzato, G. de Marco, V. Žampachová, P. Skládal, S. Pagliari, A. Rainer, P. Pinto-do-Ó, A. Caravella, K. Koci, DS. Nascimento, G. Forte
520    9_
$a RATIONALE: Cardiac ECM (extracellular matrix) comprises a dynamic molecular network providing structural support to heart tissue function. Understanding the impact of ECM remodeling on cardiac cells during heart failure (HF) is essential to prevent adverse ventricular remodeling and restore organ functionality in affected patients. OBJECTIVES: We aimed to (1) identify consistent modifications to cardiac ECM structure and mechanics that contribute to HF and (2) determine the underlying molecular mechanisms. METHODS AND RESULTS: We first performed decellularization of human and murine ECM (decellularized ECM) and then analyzed the pathological changes occurring in decellularized ECM during HF by atomic force microscopy, 2-photon microscopy, high-resolution 3-dimensional image analysis, and computational fluid dynamics simulation. We then performed molecular and functional assays in patient-derived cardiac fibroblasts based on YAP (yes-associated protein)-transcriptional enhanced associate domain (TEAD) mechanosensing activity and collagen contraction assays. The analysis of HF decellularized ECM resulting from ischemic or dilated cardiomyopathy, as well as from mouse infarcted tissue, identified a common pattern of modifications in their 3-dimensional topography. As compared with healthy heart, HF ECM exhibited aligned, flat, and compact fiber bundles, with reduced elasticity and organizational complexity. At the molecular level, RNA sequencing of HF cardiac fibroblasts highlighted the overrepresentation of dysregulated genes involved in ECM organization, or being connected to TGFβ1 (transforming growth factor β1), interleukin-1, TNF-α, and BDNF signaling pathways. Functional tests performed on HF cardiac fibroblasts pointed at mechanosensor YAP as a key player in ECM remodeling in the diseased heart via transcriptional activation of focal adhesion assembly. Finally, in vitro experiments clarified pathological cardiac ECM prevents cell homing, thus providing further hints to identify a possible window of action for cell therapy in cardiac diseases. CONCLUSIONS: Our multiparametric approach has highlighted repercussions of ECM remodeling on cell homing, cardiac fibroblast activation, and focal adhesion protein expression via hyperactivated YAP signaling during HF.
650    _2
$a adaptorové proteiny signální transdukční $x genetika $x metabolismus $7 D048868
650    _2
$a zvířata $7 D000818
650    _2
$a dilatační kardiomyopatie $x genetika $x metabolismus $x patologie $x patofyziologie $7 D002311
650    _2
$a studie případů a kontrol $7 D016022
650    _2
$a pohyb buněk $7 D002465
650    _2
$a kultivované buňky $7 D002478
650    _2
$a modely nemocí na zvířatech $7 D004195
650    _2
$a extracelulární matrix $x genetika $x metabolismus $x ultrastruktura $7 D005109
650    _2
$a fibroblasty $x metabolismus $x ultrastruktura $7 D005347
650    _2
$a srdeční selhání $x genetika $x metabolismus $x patologie $x patofyziologie $7 D006333
650    _2
$a lidé $7 D006801
650    _2
$a buněčný převod mechanických signálů $7 D040542
650    _2
$a myši inbrední C57BL $7 D008810
650    _2
$a infarkt myokardu $x genetika $x metabolismus $x patologie $x patofyziologie $7 D009203
650    _2
$a myokard $x metabolismus $x ultrastruktura $7 D009206
650    _2
$a transkripční faktory $x genetika $x metabolismus $7 D014157
650    12
$a funkce levé komory srdeční $7 D016277
650    12
$a remodelace komor $7 D020257
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
655    _2
$a audiovizuální média $7 D059040
700    1_
$a Silva, Ana Catarina $u Instituto de Investigação e Inovação em Saúde and Instituto Nacional de Engenharia Biomédica, Universidade do Porto (A.C.S., P.P.-d.Ó., D.S.N.) $u Instituto de Ciências Biomédicas Abel Salazar, Universidade do Porto, Porto, Portugal (A.C.S., P.P.-d.Ó., D.S.N.) $u Gladstone Institute University of Cardiovascular Disease, San Francisco (A.C.S., J.O.-D.L.C.)
700    1_
$a Oliver-De La Cruz, Jorge $u International Clinical Research Center, St. Anne's University Hospital Brno, Czech Republic (A.R.P., J.O.-D.L.C., F.M., V.H., G.C., O.P., V.V., S.P., K.K., G.F.) $u Gladstone Institute University of Cardiovascular Disease, San Francisco (A.C.S., J.O.-D.L.C.) $u Competence Center for Mechanobiology in Regenerative Medicine, INTERREG ATCZ133, Brno, Czech Republic (J.O.-D.L.C., F.M., V.V., G.F.)
700    1_
$a Martino, Fabiana $u International Clinical Research Center, St. Anne's University Hospital Brno, Czech Republic (A.R.P., J.O.-D.L.C., F.M., V.H., G.C., O.P., V.V., S.P., K.K., G.F.) $u Competence Center for Mechanobiology in Regenerative Medicine, INTERREG ATCZ133, Brno, Czech Republic (J.O.-D.L.C., F.M., V.V., G.F.) $u Faculty of Medicine, Department of Biology, Masaryk University, CZ-62500 Brno, Czech Republic (F.M.)
700    1_
$a Horváth, Vladimír $u International Clinical Research Center, St. Anne's University Hospital Brno, Czech Republic (A.R.P., J.O.-D.L.C., F.M., V.H., G.C., O.P., V.V., S.P., K.K., G.F.) $u Centre for Cardiovascular and Transplant Surgery, Brno, Czech Republic (V.H.)
700    1_
$a Caluori, Guido $u International Clinical Research Center, St. Anne's University Hospital Brno, Czech Republic (A.R.P., J.O.-D.L.C., F.M., V.H., G.C., O.P., V.V., S.P., K.K., G.F.) $u Central European Institute for Technology, Masaryk University, Brno, Czech Republic (G.C., P.S.)
700    1_
$a Polanský, Ondřej $u International Clinical Research Center, St. Anne's University Hospital Brno, Czech Republic (A.R.P., J.O.-D.L.C., F.M., V.H., G.C., O.P., V.V., S.P., K.K., G.F.)
700    1_
$a Vinarský, Vladimír $u International Clinical Research Center, St. Anne's University Hospital Brno, Czech Republic (A.R.P., J.O.-D.L.C., F.M., V.H., G.C., O.P., V.V., S.P., K.K., G.F.) $u Competence Center for Mechanobiology in Regenerative Medicine, INTERREG ATCZ133, Brno, Czech Republic (J.O.-D.L.C., F.M., V.V., G.F.)
700    1_
$a Azzato, Giulia $u Department of Computer Engineering, Modelling, Electronics and Systems Engineering (G.A., A.C.), University of Calabria, Rende, Italy
700    1_
$a de Marco, Giuseppe $u Information Technology Center (G.d.M.), University of Calabria, Rende, Italy
700    1_
$a Žampachová, Víta $u First Institute of Pathological Anatomy, St. Anne's University Hospital Brno and Masaryk University, Brno, Czech Republic (V.Ž.)
700    1_
$a Skládal, Petr $u Central European Institute for Technology, Masaryk University, Brno, Czech Republic (G.C., P.S.)
700    1_
$a Pagliari, Stefania $u International Clinical Research Center, St. Anne's University Hospital Brno, Czech Republic (A.R.P., J.O.-D.L.C., F.M., V.H., G.C., O.P., V.V., S.P., K.K., G.F.)
700    1_
$a Rainer, Alberto $u Università Campus Bio-Medico di Roma, Rome, Italy (A.R.) $u Institute of Nanotechnologies (NANOTEC), National Research Council, Lecce, Italy (A.R.)
700    1_
$a Pinto-do-Ó, Perpétua $u Instituto de Investigação e Inovação em Saúde and Instituto Nacional de Engenharia Biomédica, Universidade do Porto (A.C.S., P.P.-d.Ó., D.S.N.) $u Instituto de Ciências Biomédicas Abel Salazar, Universidade do Porto, Porto, Portugal (A.C.S., P.P.-d.Ó., D.S.N.)
700    1_
$a Caravella, Alessio $u Department of Computer Engineering, Modelling, Electronics and Systems Engineering (G.A., A.C.), University of Calabria, Rende, Italy
700    1_
$a Koci, Kamila $u International Clinical Research Center, St. Anne's University Hospital Brno, Czech Republic (A.R.P., J.O.-D.L.C., F.M., V.H., G.C., O.P., V.V., S.P., K.K., G.F.)
700    1_
$a Nascimento, Diana S $u Instituto de Investigação e Inovação em Saúde and Instituto Nacional de Engenharia Biomédica, Universidade do Porto (A.C.S., P.P.-d.Ó., D.S.N.) $u Instituto de Ciências Biomédicas Abel Salazar, Universidade do Porto, Porto, Portugal (A.C.S., P.P.-d.Ó., D.S.N.)
700    1_
$a Forte, Giancarlo $u International Clinical Research Center, St. Anne's University Hospital Brno, Czech Republic (A.R.P., J.O.-D.L.C., F.M., V.H., G.C., O.P., V.V., S.P., K.K., G.F.) $u Competence Center for Mechanobiology in Regenerative Medicine, INTERREG ATCZ133, Brno, Czech Republic (J.O.-D.L.C., F.M., V.V., G.F.) $u Department of Biomaterials Science, Institute of Dentistry, University of Turku, Finland (G.F.)
773    0_
$w MED00001092 $t Circulation research $x 1524-4571 $g Roč. 128, č. 1 (2021), s. 24-38
856    41
$u https://pubmed.ncbi.nlm.nih.gov/33106094 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20211013 $b ABA008
991    __
$a 20211026133125 $b ABA008
999    __
$a ok $b bmc $g 1715040 $s 1146719
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2021 $b 128 $c 1 $d 24-38 $e 20201027 $i 1524-4571 $m Circulation research $n Circ Res $x MED00001092
LZP    __
$a Pubmed-20211013

Najít záznam

Citační ukazatele

Možnosti archivace